HK1244224B - Mek抑制劑的藥物組合物及其製備方法 - Google Patents
Mek抑制劑的藥物組合物及其製備方法Info
- Publication number
- HK1244224B HK1244224B HK18103796.0A HK18103796A HK1244224B HK 1244224 B HK1244224 B HK 1244224B HK 18103796 A HK18103796 A HK 18103796A HK 1244224 B HK1244224 B HK 1244224B
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparation
- pharmaceutical composition
- mek inhibitor
- mek
- inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4355—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510283950 | 2015-05-28 | ||
PCT/CN2016/083613 WO2016188472A1 (zh) | 2015-05-28 | 2016-05-27 | Mek抑制剂的药物组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1244224B true HK1244224B (zh) | 2020-06-12 |
Family
ID=57392340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18103796.0A HK1244224B (zh) | 2015-05-28 | 2018-03-19 | Mek抑制劑的藥物組合物及其製備方法 |
Country Status (5)
Country | Link |
---|---|
US (1) | US10350198B2 (zh) |
EP (1) | EP3305292B1 (zh) |
CN (1) | CN107613978B (zh) |
HK (1) | HK1244224B (zh) |
WO (1) | WO2016188472A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024083184A1 (zh) * | 2022-10-20 | 2024-04-25 | 西藏海思科制药有限公司 | 一种egfr抑制剂的药物组合物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102020657A (zh) * | 2009-09-11 | 2011-04-20 | 上海艾力斯医药科技有限公司 | 稠合杂芳基衍生物、制备方法及其应用 |
CN102020651B (zh) | 2010-11-02 | 2012-07-18 | 北京赛林泰医药技术有限公司 | 6-芳基氨基吡啶酮甲酰胺mek抑制剂 |
CN105315291B (zh) * | 2014-08-05 | 2019-02-01 | 正大天晴药业集团股份有限公司 | 一种6-芳基氨基吡啶酮甲酰胺化合物的结晶及其制备方法 |
-
2016
- 2016-05-27 CN CN201680028975.2A patent/CN107613978B/zh active Active
- 2016-05-27 WO PCT/CN2016/083613 patent/WO2016188472A1/zh active Application Filing
- 2016-05-27 EP EP16799359.1A patent/EP3305292B1/en active Active
- 2016-05-27 US US15/577,227 patent/US10350198B2/en active Active
-
2018
- 2018-03-19 HK HK18103796.0A patent/HK1244224B/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CN107613978B (zh) | 2019-09-20 |
EP3305292A1 (en) | 2018-04-11 |
US10350198B2 (en) | 2019-07-16 |
WO2016188472A1 (zh) | 2016-12-01 |
US20180147192A1 (en) | 2018-05-31 |
EP3305292A4 (en) | 2019-03-20 |
EP3305292B1 (en) | 2022-09-14 |
CN107613978A (zh) | 2018-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201707981B (en) | Compositions of obeticholic acid and methods of use | |
HK1256608A1 (zh) | 類黃酮組合物及其使用方法 | |
IL250744A0 (en) | A method for preparing flavociclib and its pharmaceutical preparations | |
GB201817116D0 (en) | Pharmaceutical preparation of palbociclic and preparation method thereof | |
GB201514756D0 (en) | Compound and method of use | |
GB201514760D0 (en) | Compounds and method of use | |
PL3349743T3 (pl) | Sposoby i kompozycje do hamowania oddziaływania dcn1-ubc12 | |
HK1252567A1 (zh) | 被取代的苯甲酰胺和其使用方法 | |
PT3380525T (pt) | Formulações farmacêuticas e métodos que as utilizam | |
EP3373910C0 (en) | FORMULATION OF ECHINOMYCIN, METHOD OF MANUFACTURING AND METHOD OF USE THEREOF | |
GB201520349D0 (en) | Slide fastener and method of preparation | |
HK1252057A1 (zh) | 新穎的使用方法和組合物 | |
EP3485887A4 (en) | PHARMACEUTICAL COMPOSITION OF TECOVIRIMAT FOR INTRAVENOUS DELIVERY AND METHOD OF PREPARATION | |
HK1258502A1 (zh) | 用於治療高胱氨酸尿症的組合物和方法 | |
EP3389664A4 (en) | MTHFD2 CAFFEIN INHIBITORS AND USES THEREOF | |
IL249348A0 (en) | A new preparation and method for synthesis | |
HK1217303A1 (zh) | 種治療白血病的藥物組合物及其製備方法 | |
HK1214767A1 (zh) | 片劑形式的藥物組合物及其製造方法 | |
HK1245094A1 (zh) | 一種治療抑鬱症的藥物組合物及其製備方法 | |
PT3503885T (pt) | Composição farmacêutica e métodos de utilização | |
GB201511799D0 (en) | Composition and methods of treatment | |
HK1244224B (zh) | Mek抑制劑的藥物組合物及其製備方法 | |
EP3383414A4 (en) | PLANT-BASED PHARMACEUTICAL COMPOSITIONS AND PREPARATION METHOD THEREOF | |
GB201718483D0 (en) | Pharmaceutical composition for treatment of meopausal syndrome and preparation method thereof | |
GB201506808D0 (en) | Bottle and method of preparation thereof |